# Halozyme Therapeutics director Matthew Posard sells $482,146 in stock

- Source: All News
- Published: 2026-11-19T00:01:20+00:00
- Category: Business
- Original: https://www.investing.com/news/insider-trading-news/halozyme-therapeutics-director-matthew-posard-sells-482146-in-stock-93CH-5037392
- Canonical: https://groundlevelnews.com/story/halozyme-therapeutics-director-matthew-posard-sells-482-146-in-stock-4ae933/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to All News._
